SCHEMBL28882155

SCHEMBL28882155

CC1(C)OB(c2c[nH]nc2C2CCOCC2)OC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29674195 0.92 MAPK1 (0.31) MAPK1
SCHEMBL22687312 0.91 P2RX7 (0.31)
SCHEMBL19638707 0.85 MAPK1 (0.31) MAPK1
SCHEMBL28412942 0.84 MAPK1 (0.30) MAPK1
SCHEMBL25199539 0.83 JAK1 (0.32)
SCHEMBL3476918 0.77
SCHEMBL22760036 0.74 MAPK1 (0.33) MAPK1
SCHEMBL28624786 0.70 CA1 (0.32)
SCHEMBL3786184 0.70 DAO (0.33)
SCHEMBL140519 0.70 LPL (0.32) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572755-A2 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-06-25 EP disclosed
WO-2024039901-A2 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-02-22 WO disclosed
CN-110713489-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-05-31 CN disclosed
CN-110183440-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-04-22 CN disclosed
CN-114008036-A Disubstituted pyrazole compounds as ketohexokinase inhibitors 伊莱利利公司 2022-02-01 CN disclosed
CN-110862390-A Fused tricyclic compound and application thereof in medicines 广东东阳光药业有限公司 2020-03-06 CN disclosed
CN-110713489-A Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2020-01-21 CN disclosed